相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intra-articular delivery of full-length antibodies through the use of an in situ forming depot
Alexis Fayd'herbe De Maudave et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Jeffrey S. Heier et al.
LANCET (2022)
Antibodies to watch in 2022
Helene Kaplon et al.
MABS (2022)
2021 FDA approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2022)
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them
Yara Al Ojaimi et al.
PHARMACOLOGY & THERAPEUTICS (2022)
KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal diseases
Hudson D. Stern et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
Intratumoral Immunotherapy and Tumor Ablation: A Local Approach with Broad Potential
Zachary J. Senders et al.
CANCERS (2022)
Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects
Thomas Secher et al.
PHARMACEUTICS (2022)
Intratumoral Immunotherapy: From Trial Design to Clinical Practice
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2021)
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
Steve Cunningham et al.
LANCET RESPIRATORY MEDICINE (2021)
2020 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
Carlos Cruz-Teran et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment-A Systematic Review
Abhinav Thareja et al.
PHARMACEUTICS (2021)
A review of formulations of commercially available antibodies
Robert G. Strickley et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
FDA approves 100th monoclonal antibody product
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study
Shukui Qin et al.
BIODRUGS (2021)
Aducanumab: First Approval (vol 81, pg 1437, 2021)
Sohita Dhillon
DRUGS (2021)
Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
Mariam Elshiaty et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial
J. Bruce McClain et al.
VACCINE (2021)
Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration
Arghavan Soleimanizadeh et al.
ANTIBODIES (2021)
Development and application of therapeutic antibodies against COVID-19
Lin Ning et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
KSI-301: antibody biopolymer conjugate in retinal disorders
Priya R. Chandrasekaran et al.
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)
Faricimab: expanding horizon beyond VEGF
Ashish Sharma et al.
EYE (2020)
Intratumoral Immunotherapy for Early-stage Solid Tumors
Wan Xing Hong et al.
CLINICAL CANCER RESEARCH (2020)
Off-label use of bevacizumab for wet age-related macular degeneration in Europe
Tomas Bro et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
Manuel Sanchez-Felix et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Ruben Varela-Fernandez et al.
PHARMACEUTICS (2020)
Protein stability during nebulization: Mind the collection step!
Elsa Bodier-Montagutelli et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Paolo Antonio Ascierto et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Anti -mouse CX3CR1 Antibody Alleviates Cognitive Impairment, Neuronal Loss and Myelin Deficits in an Animal Model of Brain Ischemia
Bingying Du et al.
NEUROSCIENCE (2020)
Intraarticular Injection of Infliximab-Loaded Thermosensitive Hydrogel Alleviates Pain and Protects Cartilage in Rheumatoid Arthritis
Weiying Chen et al.
JOURNAL OF PAIN RESEARCH (2020)
Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients
Gail Gauvreau et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
Marie A. Printz et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2020)
Pulmonary Delivery of Biological Drugs
Wanling Liang et al.
PHARMACEUTICS (2020)
ENHANZE((R)) drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase 20
Kenneth W. Locke et al.
DRUG DELIVERY (2019)
Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis
Atsushi Ogata et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Paula Dakin et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcg Receptors: Implications for Measuring Fc Dependent Antibody Functions
Ester Lopez et al.
FRONTIERS IN IMMUNOLOGY (2019)
First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies
Sandra M. M. Irenaeus et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats
Ian K. Styles et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis
Elisa K. Boden et al.
CROHNS & COLITIS 360 (2019)
Bevacizumab for eye diseases - Legal, regulatory, and ethical overview
Vinu Jose et al.
INDIAN JOURNAL OF PHARMACOLOGY (2019)
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Jens Markus Borghardt et al.
CANADIAN RESPIRATORY JOURNAL (2018)
Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH
Y. Ilan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies
Hanne Kinnunen Bown et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Respiratory Syncytial Virus Seasonality: A Global Overview
Pablo Obando-Pacheco et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M. Souweidane et al.
LANCET ONCOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
Natalia Olchanski et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Inhalation Devices
Petra Moroni-Zentgraf et al.
CANADIAN RESPIRATORY JOURNAL (2018)
Subcutaneous delivery of monoclonal antibodies: How do we get there?
Margarida Viola et al.
JOURNAL OF CONTROLLED RELEASE (2018)
The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
Andrea Matucci et al.
RESPIRATORY RESEARCH (2018)
Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma
Mahir Igde et al.
MINERVA PEDIATRICA (2018)
A novel antibody targeting sequence 31-35 in amyloid protein attenuates Alzheimer's disease-related neuronal damage
Li Cheng et al.
HIPPOCAMPUS (2017)
MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France
Elsa Bodier-Montagutelli et al.
MABS (2017)
Effectiveness of Palivizumab in High-risk Infants and Children A Propensity Score Weighted Regression Analysis
Evan J. Anderson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis
Kok Pim Kua et al.
PHARMACOTHERAPY (2017)
Pharmacokinetic aspects of retinal drug delivery
Eva M. del Amo et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2017)
Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG
Omesh Kumar Bharti et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Effective method for drug injection into subcutaneous tissue
Hyejeong Kim et al.
SCIENTIFIC REPORTS (2017)
Pharmacokinetics of Monoclonal Antibodies
Josiah T. Ryman et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
M. Scott Harris et al.
JOURNAL OF CROHNS & COLITIS (2016)
Eye Globe Abnormalities on MR and CT in Adults: An Anatomical Approach
James Thomas Patrick Decourcy Hallinan et al.
KOREAN JOURNAL OF RADIOLOGY (2016)
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31-April 1, 2016, Tours, France
Guillaume Desoubeaux et al.
MABS (2016)
A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration
Laurence A. Hutton-Smith et al.
MOLECULAR PHARMACEUTICS (2016)
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma
Abhijit Ray et al.
ONCOTARGET (2016)
Diffusion Regulation in the Vitreous Humor
Benjamin Tillmann Kaesdorf et al.
BIOPHYSICAL JOURNAL (2015)
Nebulization as a delivery method for mAbs in respiratory diseases
Renaud Respaud et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Daniela Bumbaca Yadav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components
Hanne M. Kinnunen et al.
JOURNAL OF CONTROLLED RELEASE (2015)
A novel screening method to assess developability of antibody-like molecules
Neeraj Kohli et al.
MABS (2015)
Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans
Victoria S. Jasion et al.
NUTRITION JOURNAL (2015)
Inflammatory Joint Diseases
Guixiu Shi et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Basic histological structure and functions of facial skin
Oktay Arda et al.
CLINICS IN DERMATOLOGY (2014)
Drug delivery systems for intra-articular treatment of osteoarthritis
Mi Lan Kang et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Subcutaneous Administration of Monoclonal Antibodies in Oncology
C. Jackisch et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2014)
Ocular delivery of macromolecules
Yoo Chun Kim et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
L. Guilleminault et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Progress in intra-articular therapy
Christopher H. Evans et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups
Philip R. Cooper et al.
FRONTIERS IN PHARMACOLOGY (2014)
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wan Ling Wong et al.
LANCET GLOBAL HEALTH (2014)
Respiratory syncytial virus: current and emerging treatment options
Tiffany L. Turner et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2014)
Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2013)
Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer
Chris Wynne et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Ocular neovascularization
Peter A. Campochiaro
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Sustained release of PTH(1-34) from PLGA microspheres suppresses osteoarthritis progression in rats
Rajalakshmanan Eswaramoorthy et al.
ACTA BIOMATERIALIA (2012)
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Nebulized Anti-IL-13 Monoclonal Antibody Fab′ Fragment Reduces Allergen-Induced Asthma
Jonathan Hacha et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Electrostatic interactions of monoclonal antibodies with subcutaneous tissue
Henryk Mach et al.
THERAPEUTIC DELIVERY (2011)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Ranibizumab: treatment in patients with neovascular age-related macular degeneration
Dante J. Pieramici et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas
G Mazzolini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Local infusion of infliximab for the treatment of acute joint inflammation
M Bokarewa et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Intramuscular preparations of antipsychotics - Uses and relevance in clinical practice
AC Altamura et al.
DRUGS (2003)
分享论文
